Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas

Defining the Role of mTOR in Cancer

2007 • 2,755 citations

Insulin and insulin-like growth factor signalling in neoplasia

2008 • 1,927 citations

Analysis of apoptosis by propidium iodide staining and flow cytometry

2006 • 1,538 citations

Insulin-like growth factors and neoplasia

2004 • 1,452 citations

Advances in Male Contraception

2008 • 1,127 citations

The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights

2007 • 989 citations

Regulation of cap-dependent translation by eIF4E inhibitory proteins

2005 • 944 citations

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size

2006 • 753 citations

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

2006 • 735 citations

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

1998 • 566 citations

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

2002 • 508 citations

Ewing's Sarcoma Family of Tumors: Current Management

2006 • 491 citations

EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3

2004 • 405 citations

Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

2007 • 378 citations

A novel putative receptor protein tyrosine kinase of the met family.

1993 • 321 citations

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

2009 • 304 citations

Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1

2009 • 301 citations

Antitumor Activity of the Insulin-Like Growth Factor-I Receptor Kinase Inhibitor NVP-AEW541 in Musculoskeletal Tumors

2005 • 294 citations

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

2009 • 269 citations

Identification of the ron Gene Product as the Receptor for the Human Macrophage Stimulating Protein

1994 • 257 citations

The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts

1997 • 251 citations

Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.

1990 • 242 citations

The MET receptor tyrosine kinase in invasion and metastasis

2007 • 242 citations

Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.

1996 • 225 citations

Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.

1994 • 218 citations

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials

2008 • 162 citations

The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors

2008 • 160 citations

An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture

1987 • 155 citations

The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

2009 • 148 citations

Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody

2008 • 147 citations

Ewing’s Sarcoma: Standard and Experimental Treatment Options

2009 • 142 citations

Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

2005 • 134 citations

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

1994 • 134 citations

IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells

2008 • 120 citations

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

2006 • 120 citations

Rhabdomyosarcoma in children

2009 • 106 citations

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924

2008 • 100 citations

The Role of IGF-1R in Pediatric Malignancies

2009 • 90 citations

Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group

2010 • 83 citations

Transcriptional regulation of IGF-I receptor gene expression by the PAX3–FKHR oncoprotein

2001 • 77 citations

The Insulin-Like Growth Factor I Receptor Is Required for Akt Activation and Suppression of Anoikis in Cells Transformed by the ETV6-NTRK3 Chimeric Tyrosine Kinase

2006 • 74 citations

Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.

1998 • 71 citations

Development of IGF-IR inhibitors in pediatric sarcomas

2009 • 51 citations

Effect of Insulin-Like Growth Factor II on Protecting Myoblast Cells Against Cisplatin-Induced Apoptosis Through p70 S6 Kinase Pathway

2002 • 50 citations